Mode
Text Size
Log in / Sign up

Evidence-based guidelines support team-based perioperative glycemic management for patients with hepatocellular carcinomaNew guidance for blood sugar control before liver cancer surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that team-based perioperative glycemic management provides evidence-based guidance for hepatocellular carcinoma care.

This evidence summary synthesizes 14 documents, including 4 guidelines, 1 systematic review, 1 evidence summary, 3 expert consensus statements, and 5 randomized controlled trials, to provide guidance on perioperative glycemic management for patients with hepatocellular carcinoma. The synthesis identifies 28 best evidence items across six specific domains: team-based perioperative glycemic management, preoperative assessment management, medication and nutritional management, blood glucose monitoring and targets, complication management, and health education.

The review focuses on establishing a structured framework for healthcare professionals, particularly nursing staff, to manage glycemic levels during the perioperative period. The inclusion of various evidence types suggests a broad synthesis of current clinical practices and research findings regarding metabolic stability in this patient population.

While the summary provides clear guidance across multiple domains, it is important to note that this is an evidence synthesis rather than a primary clinical trial. The scope is limited to the 14 documents reviewed, and specific outcomes such as adverse events or individual study p-values were not reported in the synthesis. Clinical application should be integrated into existing institutional protocols for hepatocellular carcinoma management.

How this fits prior evidence

This evidence summary addresses a gap in perioperative care for patients with hepatocellular carcinoma by providing structured guidance on glycemic management. While prior coverage has identified biomarkers like M2BPGi for risk assessment and established the efficacy of DAAs and radiofrequency treatments, this synthesis focuses specifically on the metabolic management during surgery. It complements existing knowledge regarding treatment modalities by addressing a specific nursing and clinical management domain.

If you or someone you love has liver cancer and needs surgery, managing blood sugar levels is a critical part of care. A new evidence summary has pulled together the best available guidance on this topic.

The review looked at 14 documents, including guidelines, expert consensus statements, and randomized controlled trials. From these, researchers identified 28 best practice items across six key areas: team-based care, preoperative assessment, medication and nutrition, blood glucose monitoring, complication management, and health education.

This is not a single study but a synthesis of existing evidence. That means the recommendations are based on what we already know, not on new data. The summary is designed to help nurses and other healthcare professionals provide consistent, evidence-based care.

While the guidance is thorough, it's important to note that the quality of the underlying evidence varies. The review did not report on safety or side effects, so patients should discuss their individual risks with their medical team.

What this means for you:
28 evidence-based items guide blood sugar management for liver cancer surgery patients.

Common questions

What is perioperative glycemic management?

It means controlling blood sugar levels before, during, and after surgery. For liver cancer patients, this is important because high or low blood sugar can affect recovery and increase the risk of complications.

Who is this guidance for?

The guidance is for healthcare professionals, especially nurses, who care for patients with hepatocellular carcinoma (a type of liver cancer) undergoing surgery. It helps them provide consistent, evidence-based care.

How many best practice items are there?

The evidence summary identified 28 best practice items across six areas: team-based care, preoperative assessment, medication and nutrition, blood glucose monitoring, complication management, and health education.

Is this based on new research?

No, this is an evidence summary that combines findings from 14 existing documents, including guidelines, expert consensus, and clinical trials. It does not include new data from a primary study.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
ObjectiveSystematically retrieve, evaluate, and synthesize the best available evidence on perioperative glycemic management in liver cancer patients to provide evidence-based guidance for clinical nursing practice.MethodsUsing the “6S” evidence model, we conducted a top-down search of domestic and international databases, guideline portals, and professional association websites for best clinical practices, guidelines, systematic reviews, evidence summaries, expert consensus statements, and randomized controlled trials concerning perioperative glycemic management in hepatocellular carcinoma patients. The search period spanned January 2015 to December 2025. Selected literature underwent quality assessment, evidence extraction, and synthesis.ResultsA total of 14 documents were included, comprising 4 guidelines, 1 systematic review, 1 evidence summary, 3 expert consensus statements, and 5 randomized controlled trials. This yielded 28 best evidence items across six domains: team-based perioperative glycemic management for liver cancer patients, preoperative assessment management, medication and nutritional management, blood glucose monitoring and targets, complication management, and health education.ConclusionThis study summarizes the best available evidence for perioperative glycemic management in patients with hepatocellular carcinoma, providing evidence-based guidance for healthcare professionals. Each piece of evidence should be thoroughly assessed for its appropriateness and feasibility before being translated and applied in clinical practice.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.